Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C

NCT00527540 is registered in ClinicalTrials.gov with Tehran Hepatitis Center as lead sponsor.

NCT NCT00527540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00527540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C
Lead sponsor
Tehran Hepatitis Center
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
December 31, 2008
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c